-
Brazil's imprisoned Bolsonaro hospitalized ahead of surgery
-
Serbia court drops case against ex-minister over train station disaster
-
Investors watching for Santa rally in thin pre-Christmas trade
-
David Sacks: Trump's AI power broker
-
Delap and Estevao in line for Chelsea return against Aston Villa
-
Why metal prices are soaring to record highs
-
Stocks tepid in thin pre-Christmas trade
-
UN experts slam US blockade on Venezuela
-
Bethlehem celebrates first festive Christmas since Gaza war
-
Set-piece weakness costing Liverpool dear, says Slot
-
Two police killed in explosion in Moscow
-
EU 'strongly condemns' US sanctions against five Europeans
-
Arsenal's Kepa Arrizabalaga eager for more League Cup heroics against Che;sea
-
Thailand-Cambodia border talks proceed after venue row
-
Kosovo, Serbia 'need to normalise' relations: Kosovo PM to AFP
-
Newcastle boss Howe takes no comfort from recent Man Utd record
-
Frank warns squad to be 'grown-up' as Spurs players get Christmas Day off
-
Rome pushes Meta to allow other AIs on WhatsApp
-
Black box recovered from Libyan general's crashed plane
-
Festive lights, security tight for Christmas in Damascus
-
Zelensky reveals US-Ukraine plan to end Russian war, key questions remain
-
El Salvador defends mega-prison key to Trump deportations
-
Stranger Things set for final bow: five things to know
-
Grief, trauma weigh on survivors of catastrophic Hong Kong fire
-
Asian markets mixed after US growth data fuels Wall St record
-
Stokes says England player welfare his main priority
-
Australia's Lyon determined to bounce back after surgery
-
Stokes says England players' welfare his main priority
-
North Korean POWs in Ukraine seeking 'new life' in South
-
Japanese golf star 'Jumbo' Ozaki dies aged 78
-
Johnson, Castle shine as Spurs rout Thunder
-
Thai border clashes hit tourism at Cambodia's Angkor temples
-
From predator to plate: Japan bear crisis sparks culinary craze
-
Asian markets mostly up after US growth fuels Wall St record
-
'Happy milestone': Pakistan's historic brewery cheers export licence
-
Chevron: the only foreign oil company left in Venezuela
-
US denies visas to EU ex-commissioner, four others over tech rules
-
SMX Is Transitioning From Single Deployments to Supply-Chain Infrastructure
-
Each SMX Partnership Opens a Market, the Portfolio Multiplies the Value
-
CORRECTION: Nextech3D.ai Provides Shareholder Update on Krafty Labs Acquisition and Announces $321,917 CEO Investment
-
Why SMX's Partnerships Expand Value Faster Than Its Cost Base
-
Dynamite Blockchain Delivers Record Q3 2025
-
Cosmos Health Is Building a Platform, and Tariffs Are Accelerating the Strategy
-
SMX's Integrated Value Proposition: One System, Many Markets, Compounding Leverage
-
Dermata Therapeutics Announces up to $12.4 Million Private Placement Priced At-The-Market Under Nasdaq Rules
-
Goldgroup Secures Ownership of the San Francisco Gold Mine Acquiring 100% of Molimentales del Noroeste, S.A. De C.V.
-
Alta Copper Announces Filing and Mailing of Meeting Materials for the Special Meeting of Shareholders and Optionholders to be Held on January 26, 2026
-
Pantheon Resources PLC Announces TR-1: Notification of Major Holdings
-
Bridgeline Expands Footprint with Closeout Retailer Choosing HawkSearch for Its On-Site Search Experience and Personalization
-
Koepka leaves LIV Golf: official
| RYCEF | 1.29% | 15.56 | $ | |
| CMSC | 0.3% | 23.08 | $ | |
| VOD | 0.16% | 13.081 | $ | |
| RIO | -0.56% | 80.52 | $ | |
| NGG | 0.17% | 77.37 | $ | |
| SCS | 0.12% | 16.14 | $ | |
| BTI | 0.25% | 57.185 | $ | |
| GSK | 0.19% | 48.945 | $ | |
| AZN | 0.43% | 92.54 | $ | |
| CMSD | 0.13% | 23.05 | $ | |
| RELX | -0.06% | 41.105 | $ | |
| BCE | 0.63% | 22.875 | $ | |
| JRI | 0.28% | 13.448 | $ | |
| BP | -0.73% | 34.329 | $ | |
| BCC | 1.55% | 74.38 | $ | |
| RBGPF | 1.28% | 81.26 | $ |
Rare bone-eroding disease ruining lives in Kenya's poorest county
Joyce Lokonyi sits on an upturned bucket, fingers weaving palm fronds as the wind pulls her dress to expose the stump of her amputated foot, lost to a little-known disease ravaging Kenya's poorest county.
Mycetoma is a fungal or bacterial infection that enters the body through any open wound, often as tiny as a thorn prick.
Starting as tiny bumps under the skin, it gradually leads to the erosion of tissue, muscles and bone.
The fungal variety is endemic across the so-called "mycetoma belt" -- including Somalia, Sudan, Yemen and northern Kenya -- with funding and research desperately lacking.
Once the disease has reached the bone the only option is amputation.
"I was able to slightly walk, although the disease had eaten all my toes," Lokonyi, 28, told AFP.
She was shunned by the local community, she said.
"They used to say that when you go to someone's home, you will leave traces of the disease where you stand."
She was unable to afford medication despite her husband selling off his goats, and amputation became the only option.
"I accepted because I saw that it was going to kill me," she said, a pair of battered crutches lying on the sand beside her two-year-old daughter.
But she has struggled with the aftermath.
"I have become a good-for-nothing, I can't work, I can't burn charcoal, I can't do anything," she said.
- Neglected -
In Kenya's poorest county, Turkana, around 70 percent of the population lives beneath the poverty line, with healthcare limited and hard to reach.
Mycetoma disproportionately affects rural communities of farmers and herders, according to the Drugs for Neglected Diseases initiative (DNDi), a global NGO.
It was only recognised as a neglected disease by the World Health Organization in 2016. Ignorance and misdiagnosis remain widespread.
"Doctors are not aware of the disease," Borna Nyaoke-Anoke, DNDi's head of mycetoma research, told AFP.
"If you're used to donkeys, you don't start seeing zebras everywhere."
The scale of the problem is difficult to estimate, but Ekiru Kidalio, director of Lodwar Hospital in Turkana, said they "rarely go a week without finding a case".
He added that the local population, 80 percent of which is illiterate, often turns to traditional medicine.
By the time they come to hospital "the condition is already advanced such that it's not easy to reverse".
Medication is also expensive -- treatment takes up to a year and costs as much as $2,000 -- and comes with dizzying side effects.
Diagnosis and treatment are not free under Kenya's overwhelmed health system, leaving patients at the mercy of foreign donors or seeking sums that are unimaginable for subsistence farmers.
- 'Think about the worst' -
In Lodwar Hospital, lab technician John Ekai bends over his microscope and examines a suspected mycetoma sample.
"Mycetoma is a very neglected disease, no-one is giving it attention," he told AFP.
He has become the go-to man for suspected patients, handling his charges with a mischievous sense of humour that puts them at ease.
Ekai has treated more than 100 mycetoma patients in the past year, but has seen only five recoveries, with many simply vanishing back into Turkana's arid plains.
He worries for those who have disappeared: "The mycetoma will grow and grow and maybe... lead to amputation."
During AFP's visit, he examined young mother Jennifer Ekal, 19, who had lived with the disease since she was 11.
"I was in school but I decided to leave because of my foot," she said, showing her swollen and painful extremity, hidden beneath a red-and-white dishcloth.
Four doses of medication a day appeared to be helping, she said.
But as she gathered up her daughter, three-year-old Bianca, she admitted she was worried about the future.
"I do not want to think about the worst."
B.Finley--AMWN